Janux Therapeutics JANX
NASDAQ JANX
$16.96 -0.32 (-1.85%)
At close: Oct 1, 2026 · 4:00 PM EDT

Janux Therapeutics (JANX) Non Operating Income (2020 - 2026)

Updated

Janux Therapeutics' Non Operating Income came in at $9.72 million for Q2 2026, down 13.7% from $11.26 million a year earlier and down 1.4% from the prior quarter.

Analysis

Janux Therapeutics (JANX) Non Operating Income (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Janux Therapeutics reported Non Operating Income of $40.96 million, up 4.4% year-over-year; for FY2025, it came in at $44.04 million, up 47.5% from FY2024.

  • Non Operating Income has increased in each of the last three years.
  • Going back by year, Non Operating Income was $29.85 million in FY2024 (+103.3%), $14.69 million in FY2023 (+264.2%), $4.03 million in FY2022 and $257,000 in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Non Operating Income since Q4 2024.
  • Year-over-year, Non Operating Income increased in six of the last eight quarters, with growth averaging 46.3%.
  • The fastest year-over-year change in Non Operating Income over five years came in Q3 2022 (growth of 867.9%), and the weakest in Q2 2026 (a decline of 13.7%).
  • Business Quant data shows JANX's Non Operating Income at $9.85 million (Q1 2026), $10.46 million (Q4 2025) and $10.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Janux Therapeutics 1.06 Bn 1.06 Bn - 9.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.72 Mn
Mar 31, 2026 9.85 Mn
Dec 31, 2025 10.46 Mn
Sep 30, 2025 10.94 Mn
Jun 30, 2025 11.26 Mn
Mar 31, 2025 11.39 Mn
Dec 31, 2024 8.81 Mn
Sep 30, 2024 7.78 Mn
Jun 30, 2024 7.86 Mn
Mar 31, 2024 5.40 Mn
Dec 31, 2023 4.38 Mn
Sep 30, 2023 4.25 Mn
Jun 30, 2023 3.24 Mn
Mar 31, 2023 2.82 Mn
Dec 31, 2022 2.20 Mn
Sep 30, 2022 1.33 Mn
Jun 30, 2022 373,000.00
Mar 31, 2022 132,000.00
Dec 31, 2021 74,000.00
Sep 30, 2021 137,000.00
API Access

Janux Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=JANX&period=max&api_key=YOUR_API_KEY